tiprankstipranks
Biogen (DE:IDP)
XETRA:IDP

Biogen Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
18Ratings
9 Buy
9 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Biogen
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IDP Stock Price Prediction

Average Price Target

€241.44
▲(19.35% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Biogen in the last 3 months. The average price target is €241.44 with a high forecast of €311.49 and a low forecast of €197.28. The average price target represents a 19.35% change from the last price of €202.30.
Highest Price Target€311.49Average Price Target€241.44Lowest Price Target€197.28
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Cowen & Co.
€280.34
Buy
38.58%
Upside
Reiterated
Biogen price target lowered to $270 from $285 at CowenBiogen price target lowered to $270 from $285 at Cowen
Barclays
€207.66
Hold
2.65%
Upside
Reiterated
Biogen price target lowered to $200 from $210 at BarclaysBiogen price target lowered to $200 from $210 at Barclays
Guggenheim
€197.28
Hold
-2.48%
Downside
Reiterated
Biogen (BIIB) PT Lowered to $190 at GuggenheimGuggenheim analyst Yatin Suneja lowered the price target on Biogen (NASDAQ: BIIB) to $190.00 (from $192.00) while maintaining a Neutral rating.
H.C. Wainwright
€249.19
Buy
23.18%
Upside
Reiterated
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB), aTyr Pharma (NASDAQ: LIFE) and Aytu BioScience (NASDAQ: AYTU)
BMO Capital
€225.31
Hold
11.38%
Upside
Reiterated
Biogens (BIIB) "PL Remains Challenged", Focus on CLARITY-AD - BMO Maintains Stock at Market PerformBMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $217.00 price target on Biogen (NASDAQ: BIIB), following the companys most recent quarterly report.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IDP Stock Forecast FAQ

What is DE:IDP’s average 12-month price target, according to analysts?
Based on analyst ratings, Biogen’s 12-month average price target is €241.44.
    What is DE:IDP’s upside potential, based on the analysts’ average price target?
    Biogen has 19.35% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DE:IDP a Buy, Sell or Hold?
          Biogen has a conensus rating of Moderate Buy which is based on 9 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Biogen’s price target?
            The average price target for Biogen is €241.44. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is €311.49 ,the lowest forecast is €197.28. The average price target represents 19.35% Increase from the current price of €202.3.
              What do analysts say about Biogen?
              Biogen’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis